Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Austco HealthcareASX:AHC -3.09%60 EV-to-FCF is 5.26 as of Jul. 14, 2026, which is 53% below its 10-year median of 11.28. GuruFocus rates ASX:AHC with a GF Score™ of 60/100 and a GF Value™ of A$0.33 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 414 Medical Devices & Instruments companies, Austco Healthcare ranks better than 92.51% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Austco Healthcare's Enterprise Value is A$80.07 Mil.
Austco Healthcare's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was A$15.23 Mil. Therefore, Austco Healthcare's EV-to-FCF for today is 5.26.
The historical rank and industry rank for Austco Healthcare's EV-to-FCF or its related term are showing as below:
ASX:AHC'
s EV-to-FCF Range Over the Past 10 Years
Min: -47.49 Med: 11.28 Max: 324.93
Current: 5.26
During the past 13 years, the highest EV-to-FCF of Austco Healthcare was 324.93. The lowest was -47.49. And the median was 11.28.
ASX:AHC's EV-to-FCF is ranked better than 92.51% of 414
companies
in the Medical Devices & Instruments industry
Industry Median: 23.445
vs ASX:AHC: 5.26
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Austco Healthcare's PE Ratio (TTM) for today is calculated as:
Austco Healthcare's share price for today is A$0.235.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Austco Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.021.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Austco Healthcare EV-to-FCF Related Terms
Austco Healthcare EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Austco Healthcare's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Austco Healthcare's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Austco Healthcare EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Austco Healthcare's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Austco Healthcare's EV-to-FCF falls into.
Austco Healthcare's current Enterprise Value is A$80.07 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Austco Healthcare's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was A$15.23 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Austco Healthcare (ASX:AHC) has a EV-to-FCF of 5.26 as of Jul. 14, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Austco Healthcare and its competitors. This is 53% below median its historical median of 11.28. According to the industry distribution chart, Austco Healthcare ranks #31 out of 414 companies in the Medical Devices & Instruments industry, placing it in the top 7.5%.
Is Austco Healthcare's EV-to-FCF too high?
Austco Healthcare's current EV-to-FCF of 5.26 is 53% below median its 10-year median of 11.28. The Medical Devices & Instruments industry median EV-to-FCF is 23.45. Austco Healthcare's value of 5.26 is 77.6% below this industry median. Based on the distribution chart, Austco Healthcare ranks #31 out of 414 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Austco Healthcare has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Austco Healthcare's EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Austco Healthcare ranks #31 out of 414 companies for EV-to-FCF. This places Austco Healthcare in the top 8% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 23.45. Austco Healthcare's value of 5.26 is 77.6% below this benchmark. While the company's 10-year median is 11.28 vs. the industry median of 23.45, Austco Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.45, based on 414 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Austco Healthcare's current EV-to-FCF of 5.26 is 77.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Austco Healthcare and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Austco Healthcare's current EV-to-FCF is 5.26, which is 53% below median its own 10-year median of 11.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Austco Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Austco Healthcare (ASX:AHC) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.33, compared to a current price of A$0.24 — trading 28.8% below its estimated fair value. The current EV-to-FCF is 5.26, which is 53% below median its 10-year median of 11.28 and 77.6% below the Medical Devices & Instruments industry median of 23.45. Austco Healthcare's overall GF Score™ is 60/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Austco Healthcare (ASX:AHC), the current EV-to-FCF is 5.26 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Austco Healthcare (ASX:AHC) Overvalued in 2026?
Based on GuruFocus' analysis, Austco Healthcare stock appears to be undervalued.
The current stock price of A$0.24 is trading 28.8% below its estimated GF Value™ of A$0.33.
GuruFocus considers Austco Healthcare to be Modestly Undervalued.
Key valuation signals for ASX:AHC:
EV-to-FCF: 5.26 (53% below median its 10-year median of 11.28)
GF Value™: A$0.33 vs. price of A$0.24 (28.8% below fair value)
Industry Position: 77.6% below the Medical Devices & Instruments median (#31 of 414)
No single metric tells the full story. See the ASX:AHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Austco Healthcare Ltd engages in the development and provision of electronic communications and clinical management solutions. It offers Tacera, a nurse call, and healthcare communication system for healthcare professionals and patient. The group is segmented into four geographic regions consisting of Australia/New Zealand, Asia, Europe, and North America.
60GF Score
Get the complete analysis for ASX:AHC
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:AHC has been successfully added to your 
